| CTRI Number |
CTRI/2024/03/063978 [Registered on: 12/03/2024] Trial Registered Prospectively |
| Last Modified On: |
02/05/2024 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Comparison of two types of anaesthesia nerve blocks for postoperative pain management in patients undergoing robot assisted radical prostate operation |
|
Scientific Title of Study
|
Erector spinae plane block and transverse abdominis plane block for postoperative analgesia in robotic assisted radical prostatectomy- A single centre, prospective, double blind, randomised controlled trial |
| Trial Acronym |
PRO-TAPES |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| N.A. |
NIL |
| PRO-TAPES |
Protocol Number |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Srimanta Kumar Halder |
| Designation |
Consultant |
| Affiliation |
Tata Medical Center |
| Address |
Department of Onco-anaesthesia, 14 MAR (E-W), New Town, Rajarhat , Kolkata
North Twentyfour Parganas WEST BENGAL 700160 India |
| Phone |
9438910048 |
| Fax |
|
| Email |
haldarkeshab2@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Srimanta Kumar Halder |
| Designation |
Consultant |
| Affiliation |
Tata Medical Center |
| Address |
Department of Onco-anaesthesia, 14 MAR (E-W), New Town, Rajarhat , Kolkata
North Twentyfour Parganas WEST BENGAL 700160 India |
| Phone |
9438910048 |
| Fax |
|
| Email |
haldarkeshab2@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Srimanta Kumar Halder |
| Designation |
Consultant |
| Affiliation |
Tata Medical Center |
| Address |
Department of Onco-anaesthesia, 14 MAR (E-W), New Town, Rajarhat , Kolkata
North Twentyfour Parganas WEST BENGAL 700160 India |
| Phone |
9438910048 |
| Fax |
|
| Email |
haldarkeshab2@gmail.com |
|
|
Source of Monetary or Material Support
|
| Tata Medical Center, Kolkata, India |
|
|
Primary Sponsor
|
| Name |
Tata Medical Center |
| Address |
14 MAR (E-W), New Town, Rajarhat , Kolkata-700160, West Bengal, India |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Srimanta Kumar Halder |
Tata Medical Center |
Department of Onco-anaesthesia, 14 MAR (E-W), New Town, Rajarhat, Kolkata North Twentyfour Parganas WEST BENGAL |
9438910048
haldarkeshab2@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Tata Medical Center- Institutional Review Board |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Erector spinae plane block (ESPB) |
Patients will be positioned in a lateral decubitus position. At T11 probe is placed transverse to identify the midline and moved laterally to identify TP. The erector spinae muscle and transverse process will be observed by sliding the transducer to the lateral aspect from the midline by approximately 3–4 cm. The
20G, 100mm needle will be inserted superior to the ultrasound probe
using an in-plane approach in the cephalad to caudal direction. 20ml of ropivacaine 0.2%
will be injected. Same procedure will be repeated on the contralateral ESPB. This will be an one time procedure. |
| Comparator Agent |
Transversus abdominis plane block (TAPB) |
For TAPB group, the block will be performed in supine position. An ultrasound probe will be placed on the abdominal wall with a transverse orientation along the mid-axillary line, halfway between the costal margin and the anterior superior iliac spine. A 20G, 100-mm needle will be inserted into the skin just medial to the ultrasound probe. The needle will be advanced until the tip rested within the plane between internal oblique and transversus abdominis muscles. 20 mL of ropivacaine 0.2% will be injected. The same process will then be undertaken on the contralateral side of the abdomen. This will be an one time procedure. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
80.00 Year(s) |
| Gender |
Male |
| Details |
1. Patients who will undergo elective robot assisted radical prostatectomy
2. American Society of Anaesthesiology Physical Score (ASA-PS) score of I - III
3. Age- above 18 years |
|
| ExclusionCriteria |
| Details |
1. Patients receiving systemic opioids for chronic pain
2. Local site infection
3. Patient sent on mechanical ventilation to ICU postoperatively
4. Failure to give block due to technical issues |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
On-site computer system |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Intravenous morphine consumption in mg |
24 hours |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
â— Postoperative rescue fentanyl requirements in mcg in the first 24 hours
â— Numeric Rating Scale (NRS) at rest on arrival at the ICU (T0); 3 hours (T1); 6 hours (T2); 12 hours (T3); 24 hours(T4)
â— Modified Ramsay Sedation Score on arrival at the ICU (T0); 3 hours (T1); 6 hours (T2); 12 hours (T3); 24 hours( T4)
â— NRS on first ambulation
â— NRS on coughing
â— Time to enteric resumption
â— Time to ambulation
â— Time to flatus pass
â— Postoperative nausea and vomiting at the above-mentioned time points
â— Patient satisfaction score
â— Length of hospital stay |
First 24 hours |
|
|
Target Sample Size
|
Total Sample Size="29" Sample Size from India="29"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
15/03/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
With the rise in the number of robotic prostatectomy cases, the need for adequate pain relief following the surgery has become important. Due to the adverse effects related to opioids, use of opioid sparing multimodal analgesia techniques including myofascial plane blocks can be used for adequate pain relief. In this study we plan to divide the patients into two groups and use erector spinae plane and transversus abdominis plane block following surgery with local anaesthetics under ultrasound guidance. Patients would be provided with PCA pumps delivering morphine when required in the postoperative period and bolus fentanyl for breakthrough pain. Categorical data will be expressed as frequencies (percentage) and analysed using the Chi-square or Fisher exact test. Continuous variables will be presented as means +/-SD or median with interquartile range and will be compared with independent t test or Mann-Whitney U test. Statistical analysis will be performed using the Statistical Package for the Social Sciences software. Sample size calculation will be performed with the G* power 3 software. The patients will be explained about the risks and benefits of the two methods of analgesia during pre-anaesthesia check up and written informed consent will be taken. They will also be informed about Numeric Rating Scale (NRS) and trained how to operate the PCA pump. All patients will be prepared according to ERAS protocol. In both the groups, general anaesthesia will be administered and routine care will be provided. For ESPB group, patients will be positioned in a lateral decubitus position. Under ultrasound guidance following hydro-dissection 20 ml of 0.2% ropivacaine will be administered on both sides. In the TAPB group, the block will be performed in supine position. 20 ml of 0.2% ropivacaine will be given under ultrasound guidance following hydro-dissection on both sides. Outcome measures:- Primary outcome: - 24 hours intravenous morphine consumption in mg
Secondary outcome: - Postoperative rescue fentanyl requirements in mcg in the first 24 hours
- NRS at rest on arrival at the ICU (T0); 3 hours (T1); 6 hours (T2); 12 hours (T3); 24 hours (T4)
- Modified Ramsay Sedation score on arrival at the ICU (T0); 3 hours (T1); 6 hours (T2); 12 hours (T3); 24 hours (T4)
- NRS on first ambulation
- NRS on coughing
- Time to enteric resumption
- Time to ambulation
- Time to flatus pass
- Postoperative nausea and vomiting at the above mentioned time points
- Patient satisfaction score
- Length of hospital stay
|